HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

5- ((2,4- dioxo- 5- thiazolidinyl)methyl)- 2- methoxy- N- ((4- (trifluoromethyl)phenyl)methyl)benzamide

an antihyperlipidemic agent that also functions as an insulin sensitizer, PPARalpha agonist, and PPARgamma agonist; structure in first source
Also Known As:
KCL1998001079; KRP 297; KRP-297; KRP297; L 410198; L-410198; L410198; MK 767; MK-767; MK767 cpd
Networked: 4 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Yajima, Ken: 1 article (05/2003)
2. Seto, Yoshiko: 1 article (05/2003)
3. Miyashita, Kiichi: 1 article (05/2003)
4. Saruta, Takao: 1 article (05/2003)
5. Fujita, Hiroshi: 1 article (05/2003)
6. Kawai, Toshihide: 1 article (05/2003)
7. Ogawa, Takeo: 1 article (05/2003)
8. Ukeda, Kaname: 1 article (05/2003)
9. Fujita, Haruhisa: 1 article (05/2003)
10. Hirose, Hiroshi: 1 article (05/2003)

Related Diseases

1. Hyperglycemia
2. Insulin Resistance
3. Body Weight (Weight, Body)
4. Obesity

Related Drugs and Biologics

1. Insulin (Novolin)
2. PPAR alpha
3. Triglycerides (Triacylglycerol)
4. Glucose (Dextrose)
5. Carbon Monoxide
6. Bezafibrate
7. 2,4-thiazolidinedione (thiazolidinedione)
8. pioglitazone (Actos)
9. troglitazone (Rezulin)